Nanobodies¯: New ammunition to battle viruses

Antiviral Research

Volumn 92, Issue 3, 2011, Pages 389-407

  Vanlandschoot, Peter ^a   Stortelers, Catelijne ^a   Beirnaert, Els ^a   Ibañez, Lorena Itatí ^b,c   Schepens, Bert ^b,c   Depla, Erik ^a   Saelens, Xavier ^b,c  

^a ABLYNX NV   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Antiviral; Camelidae; Heavy chain only antibody; Nanobody; VHH

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; NANOBODY; NUCLEOCAPSID PROTEIN;

ANTIGEN BINDING; ANTIVIRAL THERAPY; BINDING AFFINITY; CAMELID; DIAGNOSTIC VALUE; FOOT AND MOUTH DISEASE VIRUS; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA VIRUS; MARBURGVIRUS; PLANT VIRUS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MULTIMERIZATION; RABIES VIRUS; REVIEW; ROTAVIRUS; VACCINIA VIRUS; VIRUS NUCLEOCAPSID;

EID: 80355141486     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.09.002     Document Type: Review

References (155)

1. Van den Abbeele, A., De Clercq, S., De Ganck, A., De Corte, V., Van Loo, B., Soror, S.H., Srinivasan, V., Steyaert, J., Vandekerckhove, J., Gettemans, J., A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction. Cell. Mol. Life Sci. 67 (2010), 1519–1535.
2. Barbas, C.F. 3rd, Björling, E., Chiodi, F., Dunlop, N., Cababa, D., Jones, T.M., Zebedee, S.L., Persson, M.A., Nara, P.L., Norrby, E., Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 89 (1992), 9339–9343.
3. Beekwilder, J., Houwelingen, A., Beckhoven, J., Speksnijder, A., Stable recombinant alpaca antibodies for detection of Tulip virus X. Eur. J. Plant Pathol. 121 (2008), 477–485.
4. Binley, J.M., Wrin, T., Korber, B., Zwick, M.B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., Petropoulos, C.J., Burton, D.R., Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78 (2004), 13232–13252.
5. Van Bockstaele, F., Holz, J.-B., Revets, H., The development of nanobodies for therapeutic applications. Curr. Opin. Investig. Drugs 10 (2009), 1212–1224.
6. Bouchet, J., Basmaciogullari, S.E., Chrobak, P., Stolp, B., Bouchard, N., Fackler, O.T., Chames, P., Jolicoeur, P., Benichou, S., Baty, D., Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody. Blood 117 (2011), 3559–3568.
7. Bruss, V., Hepatitis B virus morphogenesis. World J. Gastroenterol. 13 (2007), 65–73.
8. Buchacher, A., Predl, R., Strutzenberger, K., Steinfellner, W., Trkola, A., Purtscher, M., Gruber, G., Tauer, C., Steindl, F., Jungbauer, A., Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res. Hum. Retroviruses 10 (1994), 359–369.
9. Burns, J.W., Siadat-Pajouh, M., Krishnaney, A.A., Greenberg, H.B., Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272 (1996), 104–107.
10. Burton, D.R., Barbas, C.F. 3rd, Persson, M.A., Koenig, S., Chanock, R.M., Lerner, R.A., A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88 (1991), 10134–10137.
11. Burton, D.R., Pyati, J., Koduri, R., Sharp, S.J., Thornton, G.B., Parren, P.W., Sawyer, L.S., Hendry, R.M., Dunlop, N., Nara, P.L., Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266 (1994), 1024–1027.
12. Calder, L.J., González-Reyes, L., García-Barreno, B., Wharton, S.A., Skehel, J.J., Wiley, D.C., Melero, J.A., Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology 271 (2000), 122–131.
13. Conrath, K.E., Lauwereys, M., Galleni, M., Matagne, A., Frère, J.M., Kinne, J., Wyns, L., Muyldermans, S., Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae. Antimicrob. Agents Chemother. 45 (2001), 2807–2812.
14. Conrath, K., Lauwereys, M., Wyns, L., Muyldermans, S., Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 276 (2001), 7346–7350.
15. Conrath, K., Pereira, A.S., Martins, C.E., Timóteo, C.G., Tavares, P., Spinelli, S., Kinne, J., Flaudrops, C., Cambillau, C., Muyldermans, S., Moura, I., Moura, J.J.G., Tegoni, M., Desmyter, A., Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase. Protein Sci. 18 (2009), 619–628.
16. Coppieters, K., Dreier, T., Silence, K., de Haard, H., Lauwereys, M., Casteels, P., Beirnaert, E., Jonckheere, H., Van de Wiele, C., Staelens, L., Hostens, J., Revets, H., Remaut, E., Elewaut, D., Rottiers, P., Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Arthritis Rheum. 54 (2006), 1856–1866.
17. Corthésy, B., Benureau, Y., Perrier, C., Fourgeux, C., Parez, N., Greenberg, H., Schwartz-Cornil, I., Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J. Virol. 80 (2006), 10692–10699.
18. Czauderna, F., Fischer, N., Boller, K., Kurth, R., Tönjes, R.R., Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J. Virol. 74 (2000), 4028–4038.
19. Daelemans, D., Costes, S.V., Lockett, S., Pavlakis, G.N., Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo. Mol. Cell. Biol. 25 (2005), 728–739.
20. Dai, Y., Vaught, T.D., Boone, J., Chen, S.-H., Phelps, C.J., Ball, S., Monahan, J.A., Jobst, P.M., McCreath, K.J., Lamborn, A.E., Cowell-Lucero, J.L., Wells, K.D., Colman, A., Polejaeva, I.A., Ayares, D.L., Targeted disruption of the alpha1, 3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20 (2002), 251–255.
21. Daley, L.P., Kutzler, M.A., Bennett, B.W., Smith, M.C., Glaser, A.L., Appleton, J.A., Effector functions of camelid heavy-chain antibodies in immunity to West Nile virus. Clin. Vaccine Immunol. 17 (2010), 239–246.
22. Daley-Bauer, L.P., Purdy, S.R., Smith, M.C., Gagliardo, L.F., Davis, W.C., Appleton, J.A., Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas. Clin. Vaccine Immunol. 17 (2010), 2007–2015.
23. Dalgleish, A.G., Beverley, P.C., Clapham, P.R., Crawford, D.H., Greaves, M.F., Weiss, R.A., The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312 (1984), 763–767.
24. Dekker, S., Toussaint, W., Panayotou, G., de Wit, T., Visser, P., Grosveld, F., Drabek, D., Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses. J. Virol. 77 (2003), 12132–12139.
25. Deng, Y.M., Tuch, B.E., Rawlinson, W.D., Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation 70 (2000), 1010–1016.
26. Denner, J., Infectious risk in xenotransplantation – what post-transplant screening for the human recipient?. Xenotransplantation 18 (2011), 151–157.
27. Deschacht, N., De Groeve, K., Vincke, C., Raes, G., De Baetselier, P., Muyldermans, S., A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire. J. Immunol. 184 (2010), 5696–5704.
28. Desmyter, A., Decanniere, K., Muyldermans, S., Wyns, L., Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. J. Biol. Chem. 276 (2001), 26285–26290.
29. Desmyter, A., Transue, T.R., Ghahroudi, M.A., Thi, M.H., Poortmans, F., Hamers, R., Muyldermans, S., Wyns, L., Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat. Struct. Biol. 3 (1996), 803–811.
30. Dolk, E., van der Vaart, M., Lutje Hulsik, D., Vriend, G., de Haard, H., Spinelli, S., Cambillau, C., Frenken, L., Verrips, T., Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo. Appl. Environ. Microbiol. 71 (2005), 442–450.
31. Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L.G.J., Muyldermans, S., Wyns, L., Matagne, A., Single-domain antibody fragments with high conformational stability. Protein Sci. 11 (2002), 500–515.
32. Ewert, S., Cambillau, C., Conrath, K., Plückthun, A., Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains. Biochemistry 41 (2002), 3628–3636.
33. Falsey, A.R., Cunningham, C.K., Barker, W.H., Kouides, R.W., Yuen, J.B., Menegus, M., Weiner, L.B., Bonville, C.A., Betts, R.F., Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J. Infect. Dis. 172 (1995), 389–394.
34. Feld, J., Lee, J.-yee, Locarnini, S., New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38 (2003), 545–553.
35. Fischer, U., Huber, J., Boelens, W.C., Mattaj, I.W., Lührmann, R., The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82 (1995), 475–483.
36. Fornerod, M., Ohno, M., Yoshida, M., Mattaj, I.W., CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90 (1997), 1051–1060.
37. Forsman, A., Beirnaert, E., Aasa-Chapman, M.M.I., Hoorelbeke, B., Hijazi, K., Koh, W., Tack, V., Szynol, A., Kelly, C., McKnight, A., Verrips, T., de Haard, H., Weiss, R.A., Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. J. Virol. 82 (2008), 12069–12081.
38. Foster, J.L., Garcia, J.V., HIV-1 Nef: at the crossroads. Retrovirology, 5, 2008, 84.
39. Fukuda, M., Asano, S., Nakamura, T., Adachi, M., Yoshida, M., Yanagida, M., Nishida, E., CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390 (1997), 308–311.
40. Garaicoechea, L., Olichon, A., Marcoppido, G., Wigdorovitz, A., Mozgovoj, M., Saif, L., Surrey, T., Parreño, V., Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J. Virol. 82 (2008), 9753–9764.
41. De Genst, E., Silence, K., Decanniere, K., Conrath, K., Loris, R., Kinne, J., Muyldermans, S., Wyns, L., Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl. Acad. Sci. USA 103 (2006), 4586–4591.
42. Goldman, E.R., Anderson, G.P., Liu, J.L., Delehanty, J.B., Sherwood, L.J., Osborn, L.E., Cummins, L.B., Hayhurst, A., Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. Anal. Chem. 78 (2006), 8245–8255.
43. Goudsmit, J., Marissen, W.E., Weldon, W.C., Niezgoda, M., Hanlon, C.A., Rice, A.B., Kruif, J., de Dietzschold, B., Bakker, A.B.H., Rupprecht, C.E., Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J. Infect. Dis 193 (2006), 796–801.
44. Greenberg, A.S., Avila, D., Hughes, M., McKinney, E.C., Flajnik, M.F., A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 374 (1996), 168–173.
45. Groot, A.J., Verheesen, P., Westerlaken, E.J., Gort, E.H., van der Groep, P., Bovenschen, N., van der Wall, E., van Diest, P.J., Shvarts, A., Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha. Lab. Invest. 86 (2006), 345–356.
46. Groothuis, J.R., Simoes, E.A., Levin, M.J., Hall, C.B., Long, C.E., Rodriguez, W.J., Arrobio, J., Meissner, H.C., Fulton, D.R., Welliver, R.C., Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The respiratory syncytial virus immune globulin study group. N. Engl. J. Med. 329 (1993), 1524–1530.
47. Gualtero, D.F., Guzmán, F., Acosta, O., Guerrero, C.A., Amino acid domains 280–297 of VP6 and 531–554 of VP4 are implicated in heat shock cognate protein hsc70-mediated rotavirus infection. Arch. Virol. 152 (2007), 2183–2196.
48. De Haard, H.J.W., Bezemer, S., Ledeboer, A.M., Müller, W.H., Boender, P.J., Moineau, S., Coppelmans, M.-C., Verkleij, A.J., Frenken, L.G.J., Verrips, C.T., Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection. J. Bacteriol. 187 (2005), 4531–4541.
49. Hall, C.B., Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344 (2001), 1917–1928.
50. Hall, C.B., Weinberg, G.A., Iwane, M.K., Blumkin, A.K., Edwards, K.M., Staat, M.A., Auinger, P., Griffin, M.R., Poehling, K.A., Erdman, D., Grijalva, C.G., Zhu, Y., Szilagyi, P., The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360 (2009), 588–598.
51. Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E.B., Bendahman, N., Hamers, R., Naturally occurring antibodies devoid of light chains. Nature 363 (1993), 446–448.
52. Hanna, Z., Kay, D.G., Rebai, N., Guimond, A., Jothy, S., Jolicoeur, P., Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95 (1998), 163–175.
53. Harmsen, M.M., De Haard, H.J., Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77 (2007), 13–22.
54. Harmsen, M.M., Ruuls, R.C., Nijman, I.J., Niewold, T.A., Frenken, L.G., de Geus, B., Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol. Immunol. 37 (2000), 579–590.
55. Harmsen, M.M., Van Solt, C.B., Fijten, H.P.D., Van Setten, M.C., Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins. Vaccine 23 (2005), 4926–4934.
56. Harmsen, M.M., van Solt, C.B., van Zijderveld-van Bemmel, A.M., Niewold, T.A., van Zijderveld, F.G., Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy. Appl. Microbiol. Biotechnol. 72 (2006), 544–551.
57. Harmsen, M.M., van Solt, C.B., Fijten, H.P.D., van Keulen, L., Rosalia, R.A., Weerdmeester, K., Cornelissen, A.H.M., De Bruin, M.G.M., Eblé, P.L., Dekker, A., Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease. Vet. Microbiol. 120 (2007), 193–206.
58. Harmsen, M.M., Fijten, H.P.D., Dekker, A., Eblé, P.L., Passive immunization of pigs with bispecific llama single-domain antibody fragments against foot-and-mouth disease and porcine immunoglobulin. Vet. Microbiol. 132 (2008), 56–64.
59. Harmsen, M.M., van Solt, C.B., Fijten, H.P.D., Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation. Appl. Microbiol. Biotechnol. 84 (2009), 1087–1094.
60. Harmsen, M.M., Fijten, H.P.D., Engel, B., Dekker, A., Eblé, P.L., Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs. Vaccine 27 (2009), 1904–1911.
61. Hemming, V.G., Prince, G.A., Horswood, R.L., London, W.J., Murphy, B.R., Walsh, E.E., Fischer, G.W., Weisman, L.E., Baron, P.A., Chanock, R.M., Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J. Infect. Dis. 152 (1985), 1083–1087.
62. Henderson, F.W., Collier, A.M., Clyde, W.A. Jr., Denny, F.W., Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med 300 (1979), 530–534.
63. Hilleman, M.R., Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 21 (2003), 4626–4649.
64. Hinz, A., Lutje Hulsik, D., Forsman, A., Koh, W.W.-L., Belrhali, H., Gorlani, A., de Haard, H., Weiss, R.A., Verrips, T., Weissenhorn, W., Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction. PLoS ONE, 5, 2010, e10482.
65. Hmila, I., Saerens, D., Ben Abderrazek, R., Vincke, C., Abidi, N., Benlasfar, Z., Govaert, J., El Ayeb, M., Bouhaouala-Zahar, B., Muyldermans, S., A bispecific Nanobody to provide full protection against lethal scorpion envenoming. FASEB J. 24 (2010), 3479–3489.
66. Holliger, P., Hudson, P.J., Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23 (2005), 1126–1136.
67. Hultberg, A., Temperton, N.J., Rosseels, V., Koenders, M., Gonzalez-Pajuelo, M., Schepens, B., Ibañez, L.I., Vanlandschoot, P., Schillemans, J., Saunders, M., Weiss, R.A., Saelens, X., Melero, J.A., Verrips, C.T., Van Gucht, S., de Haard, H.J., Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules. PLoS ONE, 6, 2011, e17665.
68. Hultberg, A., Tremblay, D.M., de Haard, H., Verrips, T., Moineau, S., Hammarström, L., Marcotte, H., Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages. BMC Biotechnol., 7, 2007, 58.
69. Ibañez, L.I., De Filette, M., Hultberg, A., Verrips, T., Temperton, N., Weiss, R.A., Vandevelde, W., Schepens, B., Vanlandschoot, P., Saelens, X., Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. J. Infect. Dis. 203 (2011), 1063–1072.
70. Jähnichen, S., Blanchetot, C., Maussang, D., Gonzalez-Pajuelo, M., Chow, K.Y., Bosch, L., De Vrieze, S., Serruys, B., Ulrichts, H., Vandevelde, W., Saunders, M., De Haard, H.J., Schols, D., Leurs, R., Vanlandschoot, P., Verrips, T., Smit, M.J., CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc. Natl. Acad. Sci. USA 107 (2010), 20565–20570.
71. Johnson, S., Oliver, C., Prince, G.A., Hemming, V.G., Pfarr, D.S., Wang, S.C., Dormitzer, M., O'Grady, J., Koenig, S., Tamura, J.K., Woods, R., Bansal, G., Couchenour, D., Tsao, E., Hall, W.C., Young, J.F., Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J. Infect. Dis. 176 (1997), 1215–1224.
72. Kann, M., Schmitz, A., Rabe, B., Intracellular transport of hepatitis B virus. World J. Gastroenterol. 13 (2007), 39–47.
73. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.C., Montagnier, L., T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312 (1984), 767–768.
74. Klooster, R., Eman, M.R., le Duc, Q., Verheesen, P., Verrips, C.T., Roovers, R.C., Post, J.A., Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expression. J. Immunol. Methods 342 (2009), 1–12.
75. Knobel, D.L., Cleaveland, S., Coleman, P.G., Fèvre, E.M., Meltzer, M.I., Miranda, M.E.G., Shaw, A., Zinsstag, J., Meslin, F.-X., Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ. 83 (2005), 360–368.
76. Koh, W.W.L., Steffensen, S., Gonzalez-Pajuelo, M., Hoorelbeke, B., Gorlani, A., Szynol, A., Forsman, A., Aasa-Chapman, M.M.I., de Haard, H., Verrips, T., Weiss, R.A., Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1. J. Biol. Chem. 285 (2010), 19116–19124.
77. Kolkman, J.A., Law, D.A., Nanobodies-from llamas to therapeutic proteins. Drug Discov. Today: Technol. 7 (2010), e139–e146.
78. van der Laan, L.J., Lockey, C., Griffeth, B.C., Frasier, F.S., Wilson, C.A., Onions, D.E., Hering, B.J., Long, Z., Otto, E., Torbett, B.E., Salomon, D.R., Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 407 (2000), 90–94.
79. Lai, L., Kolber-Simonds, D., Park, K.-W., Cheong, H.-T., Greenstein, J.L., Im, G.-S., Samuel, M., Bonk, A., Rieke, A., Day, B.N., Murphy, C.N., Carter, D.B., Hawley, R.J., Prather, R.S., Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295 (2002), 1089–1092.
80. Lauwereys, M., Arbabi Ghahroudi, M., Desmyter, A., Kinne, J., Hölzer, W., De Genst, E., Wyns, L., Muyldermans, S., Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J. 17 (1998), 3512–3520.
81. Lavanchy, D., Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J. Clin. Virol 34:Suppl. 1 (2005), S1–S3.
82. Lavanchy, D., Chronic viral hepatitis as a public health issue in the world. Best. Pract. Res. Clin. Gastroenterol. 22 (2008), 991–1008.
83. Ledeboer, A.M., Bezemer, S., de Hiaard, J.J.W., Schaffers, I.M., Verrips, C.T., van Vliet, C., Düsterhöft, E.M., Zoon, P., Moineau, S., Frenken, L.G.J., Preventing phage lysis of Lactococcus lactis in cheese production using a neutralizing heavy-chain antibody fragment from llama. J. Dairy Sci. 85 (2002), 1376–1382.
84. van der Linden, R.H., Frenken, L.G., de Geus, B., Harmsen, M.M., Ruuls, R.C., Stok, W., de Ron, L., Wilson, S., Davis, P., Verrips, C.T., Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim. Biophys. Acta 1431 (1999), 37–46.
85. Mai, K.T., Perkins, D.G., Zhang, J., Mackenzie, C.R., ES1, a new lung carcinoma antibody – an immunohistochemical study. Histopathology 49 (2006), 515–522.
86. Malim, M.H., Hauber, J., Le, S.Y., Maizel, J.V., Cullen, B.R., The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338 (1989), 254–257.
87. Martín, M.C., Pant, N., Ladero, V., Günaydin, G., Andersen, K.K., Alvarez, B., Martínez, N., Alvarez, M.A., Hammarström, L., Marcotte, H., Integrative expression system for delivery of antibody fragments by lactobacilli. Appl. Environ. Microbiol. 77 (2011), 2174–2179.
88. Moineau, S., Applications of phage resistance in lactic acid bacteria. Antonie Van Leeuwenhoek 76 (1999), 377–382.
89. Moore, J.P., Trkola, A., Dragic, T., Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9 (1997), 551–562.
90. Moulard, M., Phogat, S.K., Shu, Y., Labrijn, A.F., Xiao, X., Binley, J.M., Zhang, M.-Y., Sidorov, I.A., Broder, C.C., Robinson, J., Parren, P.W.H.I., Burton, D.R., Dimitrov, D.S., Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120–CD4–CCR5 complexes. Proc. Natl. Acad. Sci. USA 99 (2002), 6913–6918.
91. Muhamuda, K., Madhusudana, S.N., Ravi, V., Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies. Hum. Vaccine 3 (2007), 192–195.
92. Müller, T., Dietzschold, B., Ertl, H., Fooks, A.R., Freuling, C., Fehlner-Gardiner, C., Kliemt, J., Meslin, F.X., Franka, R., Rupprecht, C.E., Tordo, N., Wanderler, A.I., Kieny, M.P., Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl. Trop. Dis., 3, 2009, e542.
93. Muyldermans, S., Atarhouch, T., Saldanha, J., Barbosa, J.A., Hamers, R., Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng. 7 (1994), 1129–1135.
94. Muyldermans, S., Cambillau, C., Wyns, L., Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem. Sci. 26 (2001), 230–235.
95. Muyldermans, S., Baral, T.N., Retamozzo, V.C., De Baetselier, P., De Genst, E., Kinne, J., Leonhardt, H., Magez, S., Nguyen, V.K., Revets, H., Rothbauer, U., Stijlemans, B., Tillib, S., Wernery, U., Wyns, L., Hassanzadeh-Ghassabeh, G., Saerens, D., Camelid immunoglobulins and nanobody technology. Vet. Immunol. Immunopathol. 128 (2009), 178–183.
96. Neville, M., Stutz, F., Lee, L., Davis, L.I., Rosbash, M., The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 7 (1997), 767–775.
97. Nguyen, V.K., Hamers, R., Wyns, L., Muyldermans, S., Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies. Mol. Immunol. 36 (1999), 515–524.
98. Nguyen, V.K., Hamers, R., Wyns, L., Muyldermans, S., Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire. EMBO J. 19 (2000), 921–930.
99. Nuttall, S.D., Krishnan, U.V., Hattarki, M., De Gori, R., Irving, R.A., Hudson, P.J., Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries. Mol. Immunol. 38 (2001), 313–326.
100. Pant, N., Hultberg, A., Zhao, Y., Svensson, L., Pan-Hammarstrom, Q., Johansen, K., Pouwels, P.H., Ruggeri, F.M., Hermans, P., Frenken, L., Boren, T., Marcotte, H., Hammarstrom, L., Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J. Infect. Dis. 194 (2006), 1580–1588.
101. Paradis, K., Langford, G., Long, Z., Heneine, W., Sandstrom, P., Switzer, W.M., Chapman, L.E., Lockey, C., Onions, D., Otto, E., Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 285 (1999), 1236–1241.
102. Parashar, U.D., Gibson, C.J., Bresse, J.S., Glass, R.I., Rotavirus and severe childhood diarrhea. Emerging Infect. Dis. 12 (2006), 304–306.
103. Patience, C., Takeuchi, Y., Weiss, R.A., Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3 (1997), 282–286.
104. Patience, C., Switzer, W.M., Takeuchi, Y., Griffiths, D.J., Goward, M.E., Heneine, W., Stoye, J.P., Weiss, R.A., Multiple groups of novel retroviral genomes in pigs and related species. J. Virol. 75 (2001), 2771–2775.
105. Pérez, J.M., Renisio, J.G., Prompers, J.J., van Platerink, C.J., Cambillau, C., Darbon, H., Frenken, L.G., Thermal unfolding of a llama antibody fragment: a two-state reversible process. Biochemistry 40 (2001), 74–83.
106. Peterson, A.T., Bauer, J.T., Mills, J.N., Ecologic and geographic distribution of filovirus disease. Emerging Infect. Dis. 10 (2004), 40–47.
107. Phelps, C.J., Koike, C., Vaught, T.D., Boone, J., Wells, K.D., Chen, S.-H., Ball, S., Specht, S.M., Polejaeva, I.A., Monahan, J.A., Jobst, P.M., Sharma, S.B., Lamborn, A.E., Garst, A.S., Moore, M., Demetris, A.J., Rudert, W.A., Bottino, R., Bertera, S., Trucco, M., Starzl, T.E., Dai, Y., Ayares, D.L., Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299 (2003), 411–414.
108. Platt, J.L., Knocking out xenograft rejection. Nat. Biotechnol. 20 (2002), 231–232.
109. Pollard, V.W., Malim, M.H., The HIV-1 Rev protein. Annu. Rev. Microbiol. 52 (1998), 491–532.
110. Prince, G.A., Hemming, V.G., Horswood, R.L., Chanock, R.M., Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 3 (1985), 193–206.
111. Rabe, B., Vlachou, A., Panté, N., Helenius, A., Kann, M., Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc. Natl. Acad. Sci. USA 100 (2003), 9849–9854.
112. Roben, P., Moore, J.P., Thali, M., Sodroski, J., Barbas, C.F. 3rd, Burton, D.R., Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68 (1994), 4821–4828.
113. Roovers, R.C., Laeremans, T., Huang, L., De Taeye, S., Verkleij, A.J., Revets, H., de Haard, H.J., en Henegouwen, P.M.P., Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies. Cancer Immunol. Immunother. 56 (2007), 303–317.
114. Russell, C.A., Jones, T.C., Barr, I.G., Cox, N.J., Garten, R.J., Gregory, V., Gust, I.D., Hampson, A.W., Hay, A.J., Hurt, A.C., de Jong, J.C., Kelso, A., Klimov, A.I., Kageyama, T., Komadina, N., Lapedes, A.S., Lin, Y.P., Mosterin, A., Obuchi, M., Odagiri, T., Osterhaus, A.D.M.E., Rimmelzwaan, G.F., Shaw, M.W., Skepner, E., Stohr, K., Tashiro, M., Fouchier, R.A.M., Smith, D.J., The global circulation of seasonal influenza A (H3N2) viruses. Science 320 (2008), 340–346.
115. Sanders, R.W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K.O., Kwong, P.D., Moore, J.P., The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76 (2002), 7293–7305.
116. Sarker, S.A., Casswall, T.H., Juneja, L.R., Hoq, E., Hossain, I., Fuchs, G.J., Hammarström, L., Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J. Pediatr. Gastroenterol. Nutr. 32 (2001), 19–25.
117. Sawyer, L.A., Antibodies for the prevention and treatment of viral diseases. Antiviral Res. 47 (2000), 57–77.
118. Serruys, B., Van Houtte, F., Farhoudi-Moghadam, A., Leroux-Roels, G., Vanlandschoot, P., Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies. J. Gen. Virol. 91 (2010), 643–652.
119. Serruys, B., Van Houtte, F., Verbrugghe, P., Leroux-Roels, G., Vanlandschoot, P., Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice. Hepatology 49 (2009), 39–49.
120. Sherwood, L.J., Osborn, L.E., Carrion, R. Jr., Patterson, J.L., Hayhurst, A., Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4. J. Infect. Dis. 196:Suppl. 2 (2007), S213–S219.
121. Simoes, E.A., Groothuis, J.R., Tristram, D.A., Allessi, K., Lehr, M.V., Siber, G.R., Welliver, R.C., Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J. Pediatr. 129 (1996), 214–219.
122. Specke, V., Rubant, S., Denner, J., Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology 285 (2001), 177–180.
123. Spinelli, S., Desmyter, A., Verrips, C.T., de Haard, H.J.W., Moineau, S., Cambillau, C., Lactococcal bacteriophage p2 receptor-binding protein structure suggests a common ancestor gene with bacterial and mammalian viruses. Nat. Struct. Mol. Biol. 13 (2006), 85–89.
124. Stewart, C.S., MacKenzie, C.R., Hall, J.C., Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naïve phage display library: preliminary findings for antivenom development. Toxicon 49 (2007), 699–709.
125. Stijlemans, B., Caljon, G., Natesan, S.K.A., Saerens, D., Conrath, K., Pérez-Morga, D., Skepper, J.N., Nikolaou, A., Brys, L., Pays, E., Magez, S., Field, M.C., De Baetselier, P., Muyldermans, S., High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis. PLoS Pathog., 7, 2011, e1002072.
126. Stijlemans, B., Conrath, K., Cortez-Retamozo, V., Van Xong, H., Wyns, L., Senter, P., Revets, H., De Baetselier, P., Muyldermans, S., Magez, S., Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J. Biol. Chem. 279 (2004), 1256–1261.
127. Stone, E., Hirama, T., Chen, W., Soltyk, A.L., Brunton, J., MacKenzie, C.R., Zhang, J., A novel pentamer versus pentamer approach to generating neutralizers of verotoxin 1. Mol. Immunol. 44 (2007), 2487–2491.
128. Stone, E., Hirama, T., Tanha, J., Tong-Sevinc, H., Li, S., MacKenzie, C.R., Zhang, J., The assembly of single domain antibodies into bispecific decavalent molecules. J. Immunol. Methods 318 (2007), 88–94.
129. Takeuchi, Y., Patience, C., Magre, S., Weiss, R.A., Banerjee, P.T., Le Tissier, P., Stoye, J.P., Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 72 (1998), 9986–9991.
130. Taylor, G., Stott, E.J., Bew, M., Fernie, B.F., Cote, P.J., Collins, A.P., Hughes, M., Jebbett, J., Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52 (1984), 137–142.
131. Thys, B., Saerens, D., Schotte, L., De Bleeser, G., Muyldermans, S., Hassanzadeh-Ghassabeh, G., Rombaut, B., A simple quantitative affinity capturing assay of poliovirus antigens and subviral particles by single-domain antibodies using magnetic beads. J. Virol. Methods 173 (2011), 300–305.
132. Thys, B., Schotte, L., Muyldermans, S., Wernery, U., Hassanzadeh-Ghassabeh, G., Rombaut, B., In vitro antiviral activity of single domain antibody fragments against poliovirus. Antiviral Res. 87 (2010), 257–264.
133. Tijink, B.M., Laeremans, T., Budde, M., Stigter-van Walsum, M., Dreier, T., de Haard, H.J., Leemans, C.R., van Dongen, G.A.M.S., Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology. Mol. Cancer Ther. 7 (2008), 2288–2297.
134. Le Tissier, P., Stoye, J.P., Takeuchi, Y., Patience, C., Weiss, R.A., Two sets of human-tropic pig retrovirus. Nature 389 (1997), 681–682.
135. Transue, T.R., De Genst, E., Ghahroudi, M.A., Wyns, L., Muyldermans, S., Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate. Proteins 32 (1998), 515–522.
136. Tremblay, D.M., Tegoni, M., Spinelli, S., Campanacci, V., Blangy, S., Huyghe, C., Desmyter, A., Labrie, S., Moineau, S., Cambillau, C., Receptor-binding protein of Lactococcus lactis phages: identification and characterization of the saccharide receptor-binding site. J. Bacteriol. 188 (2006), 2400–2410.
137. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J.P., Katinger, H., Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70 (1996), 1100–1108.
138. van der Vaart, J.M., Pant, N., Wolvers, D., Bezemer, S., Hermans, P.W., Bellamy, K., Sarker, S.A., van der Logt, C.P.E., Svensson, L., Verrips, C.T., Hammarstrom, L., van Klinken, B.J.W., Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine 24 (2006), 4130–4137.
139. Vercruysse, T., Pardon, E., Vanstreels, E., Steyaert, J., Daelemans, D., An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production. J. Biol. Chem. 285 (2010), 21768–21780.
140. Vercruysse, T., Pawar, S., De Borggraeve, W., Pardon, E., Pavlakis, G.N., Pannecouque, C., Steyaert, J., Balzarini, J., Daelemans, D., Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer. RNA Biol. 8 (2011), 316–324.
141. Verheesen, P., Roussis, A., de Haard, H.J., Groot, A.J., Stam, J.C., den Dunnen, J.T., Frants, R.R., Verkleij, A.J., Theo Verrips, C., van der Maarel, S.M., Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. Biochim. Biophys. Acta 1764 (2006), 1307–1319.
142. Vincke, C., Loris, R., Saerens, D., Martinez-Rodriguez, S., Muyldermans, S., Conrath, K., General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J. Biol. Chem. 284 (2009), 3273–3284.
143. Vu, K.B., Ghahroudi, M.A., Wyns, L., Muyldermans, S., Comparison of llama VH sequences from conventional and heavy chain antibodies. Mol. Immunol. 34 (1997), 1121–1131.
144. Walsh, E.E., Schlesinger, J.J., Brandriss, M.W., Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect. Immun. 43 (1984), 756–758.
145. Ward, R., Mechanisms of protection against rotavirus infection and disease. Pediatr. Infect. Dis. J. 28 (2009), S57–59.
146. Wassilak, S., Orenstein, W., Challenges faced by the global polio eradication initiative. Expert. Rev. Vaccines 9 (2010), 447–449.
147. Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., Cauerhff, A., Danquah, W., Rissiek, B., Scheuplein, F., Schwarz, N., Adriouch, S., Boyer, O., Seman, M., Licea, A., Serreze, D.V., Goldbaum, F.A., Haag, F., Koch-Nolte, F., Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med. Microbiol. Immunol. 198 (2009), 157–174.
148. Woolven, B.P., Frenken, L.G., van der Logt, P., Nicholls, P.J., The structure of the llama heavy chain constant genes reveals a mechanism for heavy-chain antibody formation. Immunogenetics 50 (1999), 98–101.
149. Wu, H., Pfarr, D.S., Losonsky, G.A., Kiener, P.A., Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab. Curr. Top. Microbiol. Immunol. 317 (2008), 103–123.
150. Wyatt, R., Sodroski, J., The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280 (1998), 1884–1888.
151. Xu, R., Cai, K., Zheng, D., Ma, H., Xu, S., Fan, S.-T., Molecular therapeutics of HBV. Curr. Gene Ther. 3 (2003), 341–355.
152. Yang, P.L., Althage, A., Chung, J., Chisari, F.V., Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 99 (2002), 13825–13830.
153. Zhang, J., Tanha, J., Hirama, T., Khieu, N.H., To, R., Tong-Sevinc, H., Stone, E., Brisson, J.R., MacKenzie, C.R., Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J. Mol. Biol. 335 (2004), 49–56.
154. Zhou, T., Xu, L., Dey, B., Hessell, A.J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M.B., Arthos, J., Burton, D.R., Dimitrov, D.S., Sodroski, J., Wyatt, R., Nabel, G.J., Kwong, P.D., Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445 (2007), 732–737.
155. Zoulim, F., Hepatitis B virus resistance to antiviral drugs: where are we going?. Liver. Int. 31:Suppl. 1 (2011), 111–116.